Growth Ratio Summary

Growth Score : 10.00

Panacea Biotec demonstrates strong growth across key metrics. The revenue growth rate, operating profit growth rate, earnings per share growth, asset growth rate and net income growth rate show high. This suggests the company is effectively expanding its operations and increasing its profitability. High growth score can attract investors and support future development.

Financial Ratio Summary

Financial Score : 4.00

The financial ratios for Panacea Biotec present a mixed view. The cash earnings per share and book value per share scored well, indicating positive aspects of the company's financial health. However, the adjusted earnings per share, dividend per share, and capital expenditures scored poorly. The overall financial score suggests a need for improvements in key areas to enhance financial performance.

Profitability Ratio Summary

Profitability Score : 4.80

The profitability ratios for Panacea Biotec present a mixed performance. The return on equity (ROE) and net margin scored well, indicating some areas of strength. However, the gross profit margin, return on capital employed (ROCE), return on assets (ROA) and operating margin scored poorly. Overall profitability needs improvement.

Efficiency Ratio Summary

Efficiency Score : 4.67

The efficiency ratios for Panacea Biotec are mixed. While days sales in inventory and receivable days scored well, indicating high efficiency in these areas, fixed asset turnover ratio, inventory turnover ratio, receivables turnover ratio and capital turnover ratio scored poorly. This suggests there are inefficiencies in utilizing assets and managing turnover. Improving these ratios could enhance the company's operational performance.

Coverage Ratio Summary

Coverage Score : 2.00

The coverage ratios for Panacea Biotec are weak. Both the interest coverage ratio and equity dividend coverage ratio scored poorly. This suggests the company may face challenges in meeting its interest and dividend obligations. A low coverage score can indicate financial strain and affect investor confidence.

Solvency Ratio Summary

Solvency Score : 10.00

Panacea Biotec demonstrates strong solvency. This indicates a solid long-term financial position, with the company effectively managing its debt and equity. A high solvency score suggests the company is financially stable and has a lower risk of financial distress. This can enhance investor confidence and support long-term growth.

Liquidity Ratio Summary

Liquidity Score : 2.00

The liquidity position of Panacea Biotec is weak. All the liquidity metrics, including the current ratio, quick ratio, cash ratio and operating cash flow ratio scored poorly. This suggests the company may face challenges in meeting its short-term obligations. A low liquidity score can impact investor confidence and the company's ability to fund operations and growth initiatives.